3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Terminated
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
22
Genitourinary
9
Gynecologic
8
Thoracic
7
Gastrointestinal
7
Dermatologic
5
Breast
4
Other solid neoplasm
3
Endocrine
2
Sarcoma
1
Other
1
Lymphoid
1
Conditions
Mucositis
27
Opioid-Induced Constipation
20
Constipation
18
Head and Neck Neoplasms
14
Stomatitis
13
Pain
12
Neoplasms
7
Obesity
6
Intestinal Diseases
5
Bronchiolitis Obliterans Syndrome
5
Oral Ulcer
3
Lymphoma, Follicular
3
Hematologic Neoplasms
3
Chemotherapy-induced Peripheral Neuropathy
3
Breast Neoplasms
3
Xerostomia
2
Venous Thromboembolism
2
Tumor Lysis Syndrome
2
Thrombocytopenia
2
Teratogenesis
2
Sexual Dysfunctions, Psychological
2
Sexual Dysfunction, Physiological
2
Renal Insufficiency
2
Prostatic Neoplasms
2
Peripheral Nervous System Diseases
2
Overweight
2
Obesity, Morbid
2
Neutropenia
2
Myocardial Infarction
2
Myelodysplastic Syndromes
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Oropharyngeal Neoplasms
×
Other
×
Clear all
NCT04648020
2023-05-31
VOICE
Monopar Therapeutics
Phase 2/3
Terminated
190 enrolled